Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 513 Neoplasms 381 Lymphoma 341 Prostatic Neoplasms 291 Melanoma 284 Carcinoma, Non-Small-Cell Lung 278 Precursor Cell Lymphoblastic Leukemia-Lymphoma 264 Lung Neoplasms 257 Leukemia, Lymphocytic, Chronic, B-Cell 249 Leukemia, Myeloid, Acute 236 Leukemia 235 Lymphoma, Non-Hodgkin 227 Colonic Neoplasms 226 Ovarian Neoplasms 208 Lymphoma, Large B-Cell, Diffuse 208 Multiple Myeloma 207 Brain Neoplasms 206 Colorectal Neoplasms 203 Lymphoma, Follicular 201 Rectal Neoplasms 194 Burkitt Lymphoma 183 Neoplasm Metastasis 180 Carcinoma, Renal Cell 172 Glioblastoma 169 Sarcoma 168 Lymphoma, Mantle-Cell 166 Pancreatic Neoplasms 158 Lymphoma, B-Cell, Marginal Zone 145 Unspecified Adult Solid Tumor, Protocol Specific 141 Hodgkin Disease 141

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Healthy Subject × Clear all

NCT01935960 2016-12-23

Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers

National Cancer Institute (NCI)

Phase 1 Completed

Healthy Subject

Data powered by HemOnc (CC BY 4.0) Colophon ⚡